Ultrasound therapy developer ImaRx Therapeutics has signed an exclusive licensing agreement with the University of Nebraska Medical Center for sonothrombolysis patents by Dr. Thomas Porter.
The licensing agreement augments ImaRx’s SonoLysis therapy of blood clots, which is in clinical trials, according to the Tucson, AZ-based vendor.
By AuntMinnie.com staff writersNovember 19, 2003
Related Reading
Clinical trials begin for ImaRx, September 18, 2003
Ultrasound bubbles over into therapy, February 12, 2001
Copyright © 2003 AuntMinnie.com